Search

Your search keyword '"Musi, Gennaro"' showing total 815 results

Search Constraints

Start Over You searched for: Author "Musi, Gennaro" Remove constraint Author: "Musi, Gennaro"
815 results on '"Musi, Gennaro"'

Search Results

201. Reply by Authors

202. Impact of Resection Technique on Perioperative Outcomes and Surgical Margins after Partial Nephrectomy for Localized Renal Masses: A Prospective Multicenter Study

203. Predictors of Positive Surgical Margins after Robot-Assisted Partial Nephrectomy for Localized Renal Tumors: Insights from a Large Multicenter International Prospective Observational Project (The Surface-Intermediate-Base Margin Score Consortium).

204. Visual Abstract - Supplemental material for Synchronous Robot-Assisted Pulmonary and Urologic Resections for Cancer

206. How Can the COVID-19 Pandemic Lead to Positive Changes in Urology Residency?

207. Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies.

209. Beyond PSA: The Role of Prostate Health Index (phi)

210. Robot-assisted inguinal lymphadenectomy: preliminary experience and perioperative outcomes from an Italian referral center

211. SARS-CoV-2 Infection and High-Risk Non-Muscle-Invasive Bladder Cancer: Are There Any Common Features?

212. Correction: Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up

213. Comparison of Outcomes and Toxicity Between Extreme and Moderate Radiation Therapy Hypofractionation in Localized Prostate Cancer: A Propensity Score Analysis

214. Radioablation +/− hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): potential of imaging and biology (AIRC IG-22159)

215. Sexual function recovery after robot‐assisted radical prostatectomy: Outcomes from an Italian referral centre and predicting nomogram

216. Conditional survival of patients with stage I–III squamous cell carcinoma of the penis: temporal changes in cancer-specific mortality

217. Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up

218. MP32-17 CLINICAL RECURRENCE AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER, DEFINING OPTIMAL SURVEILLANCE AFTER SURGERY

219. MP32-16 INCIDENCE AND IMPACT OF HISTOLOGICAL VARIANTS ON SURVIVAL IN CANDIDATES FOR RADICAL CYSTECTOMY: RESULTS FROM A MULTICENTER COLLABORATION

220. Robot assisted radical prostatectomy in kidney transplant recipients: surgical, oncological and functional outcomes of two different robotic approaches

221. Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies.

223. Adjuvant radiotherapy in node positive prostate cancer patients: a debate still on. when, for whom?

224. Outcomes of robot-assisted simple enucleation of renal masses

225. Postoperative vacuum therapy following AMS™ LGX 700® inflatable penile prosthesis placement: penile dimension outcomes and overall satisfaction

226. Long-term oncologic and functional outcomes after robot-assisted partial nephrectomy in elderly patients

227. Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT)

228. Effect of Age on Cancer-specific Mortality in Patients With Urothelial Carcinoma of the Urinary Bladder: A Population-based Competing-risks Analysis Across Disease Stages.

229. Survival of contemporary patients with non-metastatic urachal vs. non-urachal adenocarcinoma of the urinary bladder.

232. Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities.

233. Conditional survival of patients with stage I–III squamous cell carcinoma of the penis: temporal changes in cancer-specific mortality.

234. Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials

235. Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer

236. Neutrophil, Platelets, and Eosinophil to Lymphocyte Ratios Predict Gleason Score Upgrading in Low-Risk Prostate Cancer Patients

237. Adherence to EAU guidelines on penile cancer translates into better outcomes: a multicenter international study

238. Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer

240. An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer

242. Thulium Laser Treatment of Upper Urinary Tract Carcinoma: A Multi-Institutional Analysis of Surgical and Oncological Outcomes

243. MP67-17 PERIOPERATIVE AND LONG-TERM ONCOLOGICAL OUTCOMES AFTER LOCAL TUMOR ABLATION FOR COMPLEX (PADUA SCORE ≥10) RENAL TUMORS: A MULTICENTER ANALYSIS.

244. PD33-05 PROPOSAL AND INTERNAL VALIDATION OF A NOMOGRAM FOR THE PREDICTION OF LOCAL RECURRENCE-FREE SURVIVAL AFTER PERCUTANEOUS ABLATION FOR cT1 RENAL MASSES.

245. MP38-16 SURVIVAL BENEFIT OF NEPHROURETERECTOMY IN SYSTEMIC THERAPY EXPOSED METASTATIC UPPER TRACT URINARY UROTHELIAL CARCINOMA PATIENTS.

246. MP22-07 CONTEMPORARY CONDITIONAL CANCER-SPECIFIC SURVIVAL RATES IN SURGICALLY TREATED NON-METASTATIC PRIMARY URETHRAL CARCINOMA.

247. PD11-10 THE IMPACT OF HISTOLOGY AND TYPE OF ENERGY USED ON ONCOLOGICAL OUTCOMES AFTER LOCAL TUMOR ABLATION OF SMALL RENAL MASSES.

248. MRI-targeted or systematic random biopsies for prostate cancer diagnosis in biopsy naïve patients: follow-up of a PRECISION trial-like retrospective cohort

249. Contemporary rates and predictors of open conversion during minimally invasive partial nephrectomy for kidney cancer

250. Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol

Catalog

Books, media, physical & digital resources